Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|August 27, 2021
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal AntibodiesPatricia Gogesch, Simone Dudek, Ger van Zandbergen, et al.
Journal of Immunotoxicology|December 10, 2024
Type 2 responses determine skin rash during recombinant interleukin-2 therapyCharline Sommer, Vanessa Neuhaus, Patricia Gogesch, et al.
Journal of Immunotoxicology|December 10, 2024
Analyzing IL-2-induced vascular leakage with an irAOP as toolPatricia Gogesch, Samira Ortega Iannazzo, Tamara Zimmermann, et al.
Vaccines|September 5, 2019
Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus VaccinePatricia Gogesch, Inessa Penner, Steffi Krauter, et al.
Journal of Immunotoxicology|December 10, 2024
Revival of recombinant IL-2 therapy - approaches from the past until todayLuise A Roser, Charline Sommer, Samira Ortega Iannazzo, et al.
Journal of Virology|August 12, 2016
In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus InfectionGeorg Kochs, Martina Anzaghe, Stefanie Kronhart, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in miceElea Conrad, Theresa K Resch, Patricia Gogesch, et al.
Plos One|August 14, 2025
Immune cells play a critical role in cytokine- and endotoxin-mediated endothelial permeabilityPatricia Gogesch, Samira Ortega Iannazzo, Nicole Rupp, et al.
Pageof 2